Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Willis

Showing results (441-450 of 470) with videos related to

Pageof 47
Sort By:
American Journal of Ophthalmology|March 15, 2025
Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular DegenerationDavid A Eichenbaum, Nancy Holekamp, Arshad M Khanani, et al.
Microbiome|December 8, 2018
Citizen science charts two major "stomatotypes" in the oral microbiome of adolescents and reveals links with habits and drinking water compositionJesse R Willis, Pedro González-Torres, Alexandros A Pittis, et al.
Proceedings. Biological Sciences|February 5, 2013
A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special?Angela D Luis, David T S Hayman, Thomas J O'Shea, et al.
Molecular Ecology|November 27, 2013
The diet of Myotis lucifugus across Canada: assessing foraging quality and diet variabilityElizabeth L Clare, William O C Symondson, Hugh Broders, et al.
Frontiers in Microbiology|January 30, 2025
Acute stress triggers sex-dependent rapid alterations in the human small intestine microbiota compositionBruno K Rodiño-Janeiro, Olfat Khannous-Lleiffe, Marc Pigrau, et al.
Ophthalmology|February 21, 2024
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2Arshad M Khanani, Aachal Kotecha, Andrew Chang, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 9, 2026
The Indiana University Brain Health Program to deliver amyloid-targeted therapy to Alzheimer's disease patientsJared R Brosch, Sophia Wang, Liana G Apostolova, et al.
Nature Communications|November 23, 2017
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 bindingDaniel W Kulp, Jon M Steichen, Matthias Pauthner, et al.
Mabs|December 30, 2021
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage librariesTom Z Yuan, Pankaj Garg, Linya Wang, et al.
The Journal of Prevention of Alzheimer'S Disease|October 25, 2022
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task ForceD Angioni, J Delrieu, O Hansson, et al.
Pageof 47

Showing results (441-450 of 470) with videos related to

Sort By:
Pageof 47
American Journal of Ophthalmology|March 15, 2025
Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular DegenerationDavid A Eichenbaum, Nancy Holekamp, Arshad M Khanani, et al.
Microbiome|December 8, 2018
Citizen science charts two major "stomatotypes" in the oral microbiome of adolescents and reveals links with habits and drinking water compositionJesse R Willis, Pedro González-Torres, Alexandros A Pittis, et al.
Proceedings. Biological Sciences|February 5, 2013
A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special?Angela D Luis, David T S Hayman, Thomas J O'Shea, et al.
Molecular Ecology|November 27, 2013
The diet of Myotis lucifugus across Canada: assessing foraging quality and diet variabilityElizabeth L Clare, William O C Symondson, Hugh Broders, et al.
Frontiers in Microbiology|January 30, 2025
Acute stress triggers sex-dependent rapid alterations in the human small intestine microbiota compositionBruno K Rodiño-Janeiro, Olfat Khannous-Lleiffe, Marc Pigrau, et al.
Ophthalmology|February 21, 2024
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2Arshad M Khanani, Aachal Kotecha, Andrew Chang, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 9, 2026
The Indiana University Brain Health Program to deliver amyloid-targeted therapy to Alzheimer's disease patientsJared R Brosch, Sophia Wang, Liana G Apostolova, et al.
Nature Communications|November 23, 2017
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 bindingDaniel W Kulp, Jon M Steichen, Matthias Pauthner, et al.
Mabs|December 30, 2021
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage librariesTom Z Yuan, Pankaj Garg, Linya Wang, et al.
The Journal of Prevention of Alzheimer'S Disease|October 25, 2022
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task ForceD Angioni, J Delrieu, O Hansson, et al.
Pageof 47